Cancer Market Research Reports & Industry Analysis

Cancer is a package of diseases marked by uncurbed growth and proliferation of anomalous cells. The illness is generally assumed to be the fruit of the impact of assorted outside factors and inner forces, such as tobacco smoking, radiation exposure, chemicals’ influences, infectious agents, inherited gene mutations, hormonal disorders, immune system conditions and mutations of other origins, among others.

Thus far, the Cancer Market has already seen noticeable progress in early-stage tumor detection and cure globally. The market for Cancer diagnostics is close to explosive growth, promising to reach approximately EUR 4 billion in value by end-2015. Further, technology discoveries will continue to afford many chances of demystifying the genetic components of the sickness, identifying specific tumor types, and observing biological reaction to cancer treatments. However, the bulk of presently available therapies do not fully protect against some unwelcomed side-effects.

The research reports in this Catalogue present global, regional and nation-level analyses of the Cancer Market development trends over different time spans. The research reports identify major bizopps emerging in the Cancer Market; examine versatile Cancer diagnostic test technologies along with their applications, besides looking into other Cancer Market issues. The research reports also profile the top players and would-be entrants, as well as offer test volume and sales projections.

Found 1730 publications
China Cancer Drug Market: Size, Trends & Forecasts (2018-2022) US$ 800.00

... Report The report entitled “China Cancer Drug Market: Size, Trends & Forecasts (2018-2022)”, provides analysis of the China cancer drug market, with detailed analysis of market size and growth, and value ...

Jun, 2018 70 pages
2018 Europe Cancer Diagnostics Market: France, Germany, Italy, Spain, UK--Supplier Shares and Sales Segment Forecasts by Test and Country, Competitive Intelligence, Emerging Technologies,... US$ 19,700.00

... suggests alternative business expansion strategies for suppliers.strong> RationaleThe cancer diagnostics market is on the verge of explosion, as the researchers ... of the disease. During the next five years, the worldwide cancer diagnostics market is promising to be an exciting, dynamic and rapidly expanding ...

Jun, 2018 820 pages
2018 Global Cancer Diagnostics Market: US, Europe, Japan--Supplier Shares and Sales Segment Forecasts by Test and Country, Competitive Intelligence, Emerging Technologies, Instrumentation... US$ 34,750.00

... suggests alternative business expansion strategies for suppliers. Rationale The cancer diagnostics market is on the verge of explosion, as the researchers approach ... of the disease. During the next five years, the worldwide cancer diagnostics market is promising to be an exciting, dynamic and rapidly expanding ...

Jun, 2018 1200 pages
2018 US Cancer Diagnostics Market: Supplier Shares and Sales Segment Forecasts by Test, Competitive Intelligence, Emerging Technologies, Instrumentation and Opportunities US$ 9,800.00

... emerging in the cancer diagnostics market during the next five years. The report examines trends in the US cancer diagnostics markets; reviews current and ... suggests alternative business expansion strategies for suppliers. Rationale The cancer diagnostics market is on the verge of explosion, as the researchers ...

Jun, 2018 620 pages
2018 UK Cancer Diagnostics Market: Supplier Shares and Sales Segment Forecasts by Test, Competitive Intelligence, Emerging Technologies, Instrumentation and Opportunities US$ 6,800.00

... emerging in the cancer diagnostics market during the next five years. The report examines trends in the UK cancer diagnostics markets; reviews current and ... suggests alternative business expansion strategies for suppliers. Rationale The cancer diagnostics market is on the verge of explosion, as the researchers ...

Jun, 2018 565 pages
2018 Spain Cancer Diagnostics Market: Supplier Shares and Sales Segment Forecasts by Test, Competitive Intelligence, Emerging Technologies, Instrumentation and Opportunities US$ 6,800.00

... suggests alternative business expansion strategies for suppliers. Rationale The cancer diagnostics market is on the verge of explosion, as the researchers approach ... of the disease. During the next five years, the worldwide cancer diagnostics market is promising to be an exciting, dynamic and rapidly expanding ...

Jun, 2018 565 pages
2018 Japan Cancer Diagnostics Market: Supplier Shares and Sales Segment Forecasts by Test, Competitive Intelligence, Emerging Technologies, Instrumentation and Opportunities US$ 7,600.00

... suggests alternative business expansion strategies for suppliers. Rationale The cancer diagnostics market is on the verge of explosion, as the researchers approach ... of the disease. During the next five years, the worldwide cancer diagnostics market is promising to be an exciting, dynamic and rapidly expanding ...

Jun, 2018 590 pages
2018 Italy Cancer Diagnostics Market: Supplier Shares and Sales Segment Forecasts by Test, Competitive Intelligence, Emerging Technologies, Instrumentation and Opportunities US$ 6,800.00

... suggests alternative business expansion strategies for suppliers. Rationale The cancer diagnostics market is on the verge of explosion, as the researchers approach ... of the disease. During the next five years, the worldwide cancer diagnostics market is promising to be an exciting, dynamic and rapidly expanding ...

Jun, 2018 570 pages
2018 Germany Cancer Diagnostics Market: Supplier Shares and Sales Segment Forecasts by Test, Competitive Intelligence, Emerging Technologies, Instrumentation and Opportunities US$ 6,800.00

... suggests alternative business expansion strategies for suppliers. Rationale The cancer diagnostics market is on the verge of explosion, as the researchers approach ... of the disease. During the next five years, the worldwide cancer diagnostics market is promising to be an exciting, dynamic and rapidly expanding ...

Jun, 2018 585 pages
2018 France Cancer Diagnostics Market: Supplier Shares and Sales Segment Forecasts by Test, Competitive Intelligence, Emerging Technologies, Instrumentation and Opportunities US$ 6,800.00

... suggests alternative business expansion strategies for suppliers. Rationale The cancer diagnostics market is on the verge of explosion, as the researchers approach ... of the disease. During the next five years, the worldwide cancer diagnostics market is promising to be an exciting, dynamic and rapidly expanding ...

Jun, 2018 585 pages
Europe Cervical Cancer Diagnostic Market & Forecast, By Test Type (Pap smear and HPV DNA), Countries (United Kingdom, France, Germany, Italy, Spain, Sweden, Switzerland, Norway and... US$ 1,290.00

... Cancer Diagnostic Market & Forecast, By Test Type (Pap smear and HPV DNA), Countries (United Kingdom, France, Germany, Italy, Spain, Sweden, Switzerland, Norway and Netherlands)” provides a complete analysis of Europe Cervical Cancer Screening Market. The covers European Countries Cervical Cancer Test Market ...

Jun, 2018
Asia Cervical Cancer Diagnostic Market, By Test Type (Pap smear, HPV DNA and VIA), Countries (Japan, Korea, Singapore, Malaysia, India, China, Thailand and Indonesia) & Forecast US$ 1,290.00

... cancer test market in the developing countries. Renub Research report titled “Asia Cervical Cancer Diagnostic Market, By Test Type (Pap smear, HPV DNA and VIA), Countries (Japan, Korea, Singapore, Malaysia, India, China, Thailand and Indonesia) & Forecast” provides a complete analysis of Asia Cervical Cancer ...

Jun, 2018
Ovarian Cancer: KOL Insight US$ 8,495.00

... play a role? Twelve of the world’s leading KOLs from the US and Europe offer candid insights on four marketed therapies and nine Phase ... ? Could ImmunoGen’s antibody-drug conjugate IMGN853 have a potential role in ovarian cancer? KOLs debate the potential advantages and pitfalls to this novel approach ...

Apr, 2018
Global Non-small Cell Lung Cancer Therapeutics Industry Market Research 2018 US$ 2,600.00

... the Non-small Cell Lung Cancer Therapeutics market challenges to market growth? 10. What are the Non-small Cell Lung Cancer Therapeutics market opportunities and threats faced by the vendors in the global Non-small Cell Lung Cancer ...

Jun, 2018 165 pages
Ocular Cancer Drug Development Pipeline Review, 2018 US$ 3,995.00

Ocular Cancer Drug Development Pipeline Review, 2018 SUMMARY This report provides an overview of the pipeline landscape for ocular cancer and comprehensive information on the therapeutics under development and key players ...

May, 2018 63 pages
Pancreatic Cancer: Epidemiology Forecast to 2026 US$ 3,995.00

... ; and diagnosed incident cases of pancreatic cancer (excluding PNETs) by KRAS mutations. The pancreatic cancer epidemiology forecast report is written and developed by ... disease trends in the 7MM. REASONS TO BUY The Pancreatic Cancer Epidemiology Forecast report will allow you to - Develop business strategies ...

Apr, 2018 42 pages
Colorectal Cancer: Competitive Landscape to 2026 US$ 3,495.00

... growth over the next decade (2016-2026). SCOPE GlobalData’s Colorectal Cancer: Competitive Landscape to 2026 combines data from the Pharma Intelligence Center with ...

Apr, 2018 53 pages
Breast Cancer Therapeutics in Asia-Pacific Markets to 2024 - Growth Driven by Increasing Uptake of Targeted Therapies and Rising Prevalence US$ 4,995.00

Breast Cancer Therapeutics in Asia-Pacific Markets to 2024 - Growth Driven by Increasing Uptake of Targeted Therapies and Rising Prevalence SUMMARY Breast cancer is the second most common cancer ... , Kadcyla, Perjeta and Kisqali. SCOPE The breast cancer Asia-Pacific market will be valued at $4.75 billion in ...

May, 2018 215 pages
Breast Cancer Diagnostic and Drug Technologies: Global Markets US$ 5,500.00 US$ 4,950.00

... current report. This report includes market estimates for breast cancer diagnostics (mammography, biopsy and companion diagnostics), therapeutics along with market share of therapeutics by drug class (HER2 inhibitors, mitotic ...

May, 2018 154 pages
2018 Cancer Diagnostic Instrumentation: Operating Characteristics, Features and Selling Prices of Leading Automated and Semiautomated Analyzers US$ 950.00

This report reviews current instrumentation technologies, and compares features of major automated and semiautomated analyzers used for tumor marker testing. Contains 25 pages

May, 2018 25 pages
2018 Emerging Cancer Diagnostic Technologies and Market Applications US$ 1,850.00

... , biosensors, and their potential applications for cancer diagnostic testing. Also included is a review of competing/complementing technologies, such as CT, MRI, NMR, PET and photonics ...

May, 2018 110 pages
2018 Cancer Diagnostic Instrumentation: Tumor Marker Testing Analyzers and Strategic Profiles of Leading Suppliers US$ 3,850.00

... reviews current instrumentation technologies, and compares features of major automated and semiautomated analyzers used for tumor marker testing. ... presents strategic assessments of current and emerging suppliers of tumor marker diagnostic products, including their sales, product portfolios, distribution tactics ...

May, 2018 119 pages
Global Radiation Oncology Market Trends and Drivers, Restraints, and Opportunities 2018-2024 US$ 2,750.00

Global Radiation Oncology Market – Drivers, Restraints, Opportunities, Trends, and Forecasts: 2018–2024 Overview: Radiation oncology is a medical specialty that uses high energy radiation ... healthcare awareness among the public. Market Analysis: The “Global Radiation Oncology” market is estimated to witness a ...

Feb, 2018 103 pages
Global Cancer Diagnostics market and Drivers, Restraints, and Opportunities 2018-2024 US$ 2,750.00

... are some of the factors hampering the market growth to an extent. Market Analysis: The “Global Cancer Diagnostics Market” is estimated to witness a CAGR ... The global cancer diagnostics market by application is segmented into lung cancer, breast cancer, Colorectal cancer, prostate cancer and others. Lung cancer ...

Dec, 2017 118 pages
Oral Cavity (Mouth) Cancer Global Clinical Trials Review, H1, 2018 US$ 2,500.00

... of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). GlobalData Clinical Trial Reports ...

Apr, 2018 229 pages
Non-Small Cell Lung Cancer Global Clinical Trials Review, H1, 2018 US$ 2,500.00

... 's clinical trial report, “Non-Small Cell Lung Cancer Global Clinical Trials Review, H1, 2018' provides an overview of Non-Small Cell Lung Cancer clinical trials scenario. This report provides top line data relating to the clinical trials on Non-Small Cell Lung Cancer. Report includes an overview of trial ...

Mar, 2018 3085 pages
Oncology Biosimilars Market: Global Industry Analysis, Trends, Market Size and Forecasts up to 2024 US$ 4,795.00

... REPORT DELIVERS? 1. Comprehensive analysis of global as well as regional markets of oncology biosimilars market. 2. Complete coverage of all the segments in oncology biosimilars market to analyze the trends, developments in the global ...

Mar, 2018 100 pages
Lung Cancer Therapeutics Market: Global Industry Analysis, Trends, Market Size and Forecasts up to 2024 US$ 4,795.00

... The global lung cancer therapeutics market is segmented on the basis of type of molecule and disease type. Global Lung Cancer Therapeutics Market by Type of Molecule Small Molecules Biologics Global Lung Cancer Therapeutics Market by Disease ...

Mar, 2018 100 pages
Gastric Cancer Drugs Market: Global Industry Analysis, Trends, Market Size and Forecasts up to 2024 US$ 4,795.00

... type. Global Gastric Cancer Drugs Market by Route of Administration Oral Parenteral Global Gastric Cancer Drugs Market by Lines of Chemotherapy First-Line Chemotherapy Second-Line Chemotherapy Global Gastric Cancer Drugs Market by Molecule Type ...

Mar, 2018 100 pages
Global Cancer Biomarker Market Research Report - Forecast to 2023 US$ 4,450.00 US$ 4,005.00

... -stage clinical trials are fueling the growth of this market. The global cancer biomarker market is segmented on the basis of type, application, ... influence the global cancer biomarker market To provide a detailed analysis of the value chain and supply chain of the global cancer biomarker market Target Audience ...

Feb, 2018 144 pages
Head and Neck Cancers: Epidemiology Forecast to 2026 US$ 3,995.00

... Japan. SCOPE The Head and Neck Cancers Epidemiology report provides an overview of the risk factors and global trends of head and neck cancers in the seven major ... of disease trends in the 7MM. REASONS TO BUY The head and neck cancers epidemiology report will allow you to - Develop business strategies by ...

Mar, 2018 47 pages
Oncology Nutrition Market by Cancer Type (Head & Neck, Stomach & Gastrointestinal, Liver, Pancreatic, Esophageal, Lung, Breast, Blood) - Global Forecast to 2023 US$ 16,000.00

... .” Based on cancer type, the oncology nutrition market is segmented into head & neck cancers, stomach & gastrointestinal cancers, pancreatic cancer, liver cancer, esophageal cancer, lung cancer, breast cancer, blood cancer, and other cancers. The ...

Apr, 2018 97 pages
Natural Killer Cell Lymphomas Global Clinical Trials Review, H1, 2018 US$ 2,500.00

... of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). GlobalData Clinical Trial Reports ...

Mar, 2018 147 pages
Multiple Myeloma (Kahler Disease) Global Clinical Trials Review, H1, 2018 US$ 2,500.00

... coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). GlobalData Clinical Trial Reports ...

Feb, 2018 1556 pages
Bladder Cancer: Dynamic Market Forecast to 2026 US$ 8,495.00

Bladder Cancer: Dynamic Market Forecast to 2026 SUMMARY Bladder cancer is a rapidly evolving field in which new developments are constantly influencing the market landscape. The Dynamic Market Forecast is designed to help clients stay abreast ...

Mar, 2018 54 pages
Head and Neck Cancer Therapeutics in Asia-Pacific Markets to 2023 - Launch of Premium Immunotherapies and Increasing Prevalence to Drive the Market US$ 4,995.00

Head and Neck Cancer Therapeutics in Asia-Pacific Markets to 2023 - Launch of Premium Immunotherapies and Increasing Prevalence to Drive the Market SUMMARY Head and neck cancer ... incidence of cancer due to the human papillomavirus continues to ... consisting of chemotherapies, targeted therapies ... number of mAbs are ...

Dec, 2017 155 pages
Colorectal Cancer: Update Bulletin #2 [March 2018] US$ 1,095.00

... on the new clinical data presented at the ASCO 2018 Gastrointestinal Cancers Symposium for Taiho Oncology’s Lonsurf (trifluridine and tipiracil); views ...

Mar, 2018
Breast Cancer: Update Bulletin #3 US$ 1,095.00

... events that have the potential to impact the treatment landscape of breast cancer (BC). Topics covered include expert opinions on: the FDA approval of Lynparza ...

Feb, 2018
Bladder Cancer: Update Bulletin #2 [February 2018] US$ 1,095.00

... intermediate- and high-risk non-muscle invasive bladder cancer (NMIBC); KOLs offering their updated opinions on the the supply status of the ... thoughts on PD-L1 expression and its future use as a biomarker in patients with bladder cancer? Do KOLs hold any other concerns about dual immunotherapy combinations ...

Feb, 2018
Global Personalized Cancer Vaccine Market Opportunity & Clinical Innovation Trend Outlook 2024 US$ 2,400.00

... Working Mechanism of Personalized Cancer Vaccine Relevance of Biomarkers In Personalized Vaccines Developmental Cost Analysis of a Personalized Cancer Vaccine Advancements in the Personalized Cancer Vaccine Personalized Cancer Vaccine Market Analysis by Cancer Vaccines are therapeutics that helps protect ...

Apr, 2018 140 pages
Global Prostate Cancer Testing Market 2018-2022 US$ 3,500.00 US$ 2,500.00

... using a systematic 12-core method. Technavio’s analysts forecast the global prostate cancer testing market to grow at a CAGR of 10.96% during the period 2018-2022. ... and the growth prospects of the global prostate cancer testing market for 2018-2022. To calculate the market size, the report presents a detailed ...

Apr, 2018 134 pages
Global PARP Inhibitors Cancer Therapy Market, Price, Dosage & Clinical Pipeline Outlook 2023 US$ 2,200.00

... the location. “Global PARP Inhibitors Cancer Therapy Market, Price, Dosage & Clinical Pipeline Outlook 2023” report highlights: Current Market Trends & Development ... of BRCA 1 and BRCA 2 genes have an increased risk of certain types of cancer such as breast cancer, ovarian cancer and prostate cancer. Cells ...

Apr, 2018
Head and Neck Cancer Diagnostics Market: Global Industry Analysis, Trends, Market Size and Forecasts up to 2023 US$ 4,795.00

... SEGMENT COVERED The global head and neck cancer diagnostics market is segmented on the basis of diagnostic methods. Global Head And Neck Cancer Diagnostics Market by Diagnostic Methods Diagnostic Imaging Endoscopy Screening Bioscopy ...

Mar, 2018 100 pages
Colorectal Cancer Diagnostic and Treatment Market - Forecasts from 2018 to 2023 US$ 3,800.00

... hold a significant market share in the global colorectal cancer diagnostic and treatment market. This research study examines the current market ... clients in gaining faster and efficient understanding of the global colorectal cancer diagnostic and treatment market. Major industry players profiled as part of the ...

Mar, 2018 89 pages
Therapies and Diagnostics for Ovarian Cancer: Global Markets to 2022 US$ 5,500.00 US$ 4,950.00

... markets for novel products, diagnostics and therapeutics development. The report covers the regulatory environment, current and new technologies, ovarian cancer incidence, market projections and market ... covers global and regional markets for ovarian cancer diagnostics and therapies, providing reasons for ...

Apr, 2018 168 pages
Global Peptide Cancer Vaccine Market Report 2018 US$ 2,350.00

... maintained a relatively optimistic growth, the past four years, Peptide Cancer Vaccine market size to maintain the average annual growth rate of ... next few years, Peptide Cancer Vaccine market size will be further expanded, we expect that by 2022, The market size of the Peptide Cancer Vaccine will reach 650 ...

Apr, 2018 118 pages
Global Breast Cancer Screening Market Report 2018 US$ 2,350.00

... maintained a relatively optimistic growth, the past four years, Breast Cancer Screening market size to maintain the average annual growth rate of ... next few years, Breast Cancer Screening market size will be further expanded, we expect that by 2022, The market size of the Breast Cancer Screening will reach xxx ...

Apr, 2018 120 pages
Promising Outlook - US Cancer Vaccine Market US$ 1,400.00

... option. According to the RNCOS report entitled “Promising Outlook - US Cancer Vaccine Market”, the US is largest market for cancer vaccines amongst all the geographic regions ... has been segmented into three types, namely, liver cancer, HPV related cancer, and others. On the basis of type of vaccine, the market ...

Apr, 2018 135 pages
US Breast Cancer Lumpectomy Market, Treatment Cost & Opportunity Analysis 2024 US$ 2,400.00

... License depending on the location. “US Breast Cancer Lumpectomy Market, Treatment Cost & Opportunity Analysis 2024” Report Highlights: Lumpectomy Procedure & Cost Involved Lumpectomy & Mastectomy Reimbursement Analysis Lumpectomy Market Analysis by Technology Presence of Venture ...

Mar, 2018 100 pages
Non-Small Cell Lung Cancer (NSCLC) - Dynamic Market Forecast to 2025 US$ 8,495.00

Non-Small Cell Lung Cancer (NSCLC) - Dynamic Market Forecast to 2025 SUMMARY The NSCLC therapeutics market is a rapidly evolving field in which new developments ... designed to help clients stay abreast of the latest news in the NSCLC space, including regulatory, commercial, and clinical events, and to understand ...

Aug, 2017 65 pages
1 2 3 4 5 >
Skip to top